MedPath

Shanghai Renji Hospital,Shanghai Jiaotong University,School of Medicine

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of Remimazolam Tosylate for Sedation in Gastroscopy

Not Applicable
Recruiting
Conditions
Sedation Complication
Hypoxia
Propofol Adverse Reaction
Gastric Cancer
Interventions
First Posted Date
2021-01-27
Last Posted Date
2022-10-12
Lead Sponsor
RenJi Hospital
Target Recruit Count
1800
Registration Number
NCT04727034
Locations
🇨🇳

Shanghai East Hospital, Shanghai, Shanghai, China, China

🇨🇳

Renji Hospital, Shanghai, Shanghai, China, China

🇨🇳

Affiliated Hospital of Jiaxing University, Jiaxing, China

and more 2 locations

Alpha-Ketoglutarate and Abdominal Aortic Aneurysm Progression and Rupture

Not Applicable
Recruiting
Conditions
Patients With an Abdominal Aortic Aneurysm of 39-49 mm in Diameter
Interventions
Dietary Supplement: alpha-ketoglutarate
First Posted Date
2021-01-26
Last Posted Date
2021-02-21
Lead Sponsor
RenJi Hospital
Target Recruit Count
300
Registration Number
NCT04723888
Locations
🇨🇳

Cardiology, Ren Ji Hospital, Shanghai, China

Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia

Phase 4
Recruiting
Conditions
Resuscitation
Interventions
Drug: normal Saline
First Posted Date
2021-01-19
Last Posted Date
2022-10-06
Lead Sponsor
RenJi Hospital
Target Recruit Count
520
Registration Number
NCT04713358
Locations
🇨🇳

The First Affiliated Hospital of Guangxi Medical University, Guangxi, Guangxi, China

🇨🇳

Renji Hospital, Shanghai, Shanghai, China

🇨🇳

Shanghai Tong Ren Hospital, Shanghai, Shanghai, China

and more 1 locations

Comparison of Cranioplasty With PEEK and Titanium

Completed
Conditions
Brain Injuries
Hematoma of Head
Skull Defect
Interventions
Procedure: Cranioplasty
First Posted Date
2021-01-13
Last Posted Date
2021-01-13
Lead Sponsor
RenJi Hospital
Target Recruit Count
100
Registration Number
NCT04707404

Tenofovir Alafenamide for HBV Prophylaxis in HBV(-) Liver Transplant Recipients With HBcAb+ Donors

Not Applicable
Conditions
HBV
Liver Transplant Disorder
Interventions
First Posted Date
2021-01-11
Last Posted Date
2021-01-11
Lead Sponsor
RenJi Hospital
Target Recruit Count
30
Registration Number
NCT04703465

The Efficacy of Endovascular Treatment in FPOD With TASC C and D Lesions

Recruiting
Conditions
Femoropopliteal Occlusive Disease
Interventions
Procedure: endovascular treatment
First Posted Date
2021-01-06
Last Posted Date
2024-12-04
Lead Sponsor
RenJi Hospital
Target Recruit Count
1000
Registration Number
NCT04698304
Locations
🇨🇳

Renji Hospital, Shanghai, Shanghai, China

A Prospective, Randomized, Double-blinded, Multi-center Clinical Trial to Evaluate the Efficiency and Safety of Anti-PD1 Antibody (Camrelizumab) Combined With Paclitaxel(Albumin Bound) and Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer

Phase 3
Recruiting
Conditions
Pancreatic Cancer Metastatic
Pancreatic Cancer Stage IV
Interventions
Drug: Paclitaxel(Albumin Bound) and Gemcitabine
Drug: Placebo
First Posted Date
2020-12-19
Last Posted Date
2024-04-02
Lead Sponsor
RenJi Hospital
Target Recruit Count
401
Registration Number
NCT04674956
Locations
🇨🇳

Ruijin hospital, Shanghai, Shanghai, China

🇨🇳

Shanghai Cancer Center, Shanghai, Shanghai, China

🇨🇳

Zhongshan Hospital, Shanghai, Shanghai, China

and more 3 locations

Neoadjuvant PD-1 Monoclonal Antibody in Cisplatin-ineligible High Risk Upper Tract Urothelial Carcinoma

Phase 2
Completed
Conditions
Neoadjuvant Immunotherapy of Cisplatin-ineligible High Risk Upper Urinary Tract Urothelial Carcinoma
Interventions
First Posted Date
2020-12-17
Last Posted Date
2024-01-09
Lead Sponsor
RenJi Hospital
Target Recruit Count
16
Registration Number
NCT04672330
Locations
🇨🇳

Shanghai Renji Hospital, Shanghai, Shanghai, China

Neoadjuvant PD-1 Monoclonal Antibody Plus Cisplatin-based Chemotherapy in Locally Advanced Upper Tract Urothelial Carcinoma

Phase 2
Conditions
Neoadjuvant Therapy of Locally Advanced Upper Urinary Tract Urothelial Carcinoma
Interventions
Drug: Immunotherapy combined with chemotherapy
First Posted Date
2020-12-17
Last Posted Date
2020-12-17
Lead Sponsor
RenJi Hospital
Target Recruit Count
20
Registration Number
NCT04672317
Locations
🇨🇳

Shanghai Renji Hospital, Shanghai, Shanghai, China

Somatic Symptom Disorders in Patients With Myocardial Bridge

Completed
Conditions
Somatic Symptom Disorder
Myocardial Bridge
Interventions
Diagnostic Test: coronary angiography
First Posted Date
2020-12-11
Last Posted Date
2022-11-17
Lead Sponsor
RenJi Hospital
Target Recruit Count
1357
Registration Number
NCT04664387
Locations
🇨🇳

Renji Hospital, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath